A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Clinical trial NCT03834753 · COMPLETED
Trial details
- NCT number
- NCT03834753
- Sponsor
- Outlook Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2021-06-07
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.